0001654954-20-004346 Sample Contracts

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.

Purchase Agreement • April 23rd, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations

• Contract Type
  Purchase Agreement
• Filed
  April 23rd, 2020
• Company
  Edesa Biotech, Inc.
• Industry
  Pharmaceutical preparations

Purchase Agreement dated April 17, 2020 between NovImmune SA Chemin des Aulx 14, 1228 Plan-les-Ouates, Switzerland (hereinafter NI) and Edesa Biotech Research, Inc. 100 Spy Court, Markham, Ontario, Canada, L3R 5H6 (hereinafter Edesa)

SECURITIES PURCHASE AGREEMENT

Securities Purchase Agreement • April 23rd, 2020 • Edesa Biotech, Inc. • Pharmaceutical preparations • London

• Contract Type
  Securities Purchase Agreement
• Filed
  April 23rd, 2020
• Company
  Edesa Biotech, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  London

This Securities Purchase Agreement (this “Agreement”) is dated as of April 17, 2020, between Edesa Biotech, Inc., a British Columbia corporation (the “Company”), and NovImmune SA (“Purchaser”).